A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine.
about
Genetic immunization of BALB/c mice with a plasmid bearing the gene coding for a hybrid merozoite surface protein 1-hepatitis B virus surface protein fusion protects mice against lethal Plasmodium chabaudi chabaudi PC1 infectionGenetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite proteinMultistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaquesAntigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral LeishmaniasisDNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvantBoosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaquesA human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primatesDNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity.Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria.Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimenA vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animalsExpression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses.Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4.Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines.Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles.Effects of type I interferons on the adjuvant properties of plasmid granulocyte-macrophage colony-stimulating factor in vivo.The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosisGM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine.Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses.Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome.Enhancing efficacy of HIV gag DNA vaccine by local delivery of GM-CSF in murine and macaque models.Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNAA bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.DNA immunization as an efficient strategy for vaccination.Recent Developments in Preclinical DNA Vaccination.Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.Dendritic cells can initiate protective immune responses against malaria.Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques.Immune Response and Protective Efficacy of a Heterologous DNA-Protein Immunization with Leishmania Superoxide Dismutase B1.The protein family TcTASV-C is a novel Trypanosoma cruzi virulence factor secreted in extracellular vesicles by trypomastigotes and highly expressed in bloodstream forms.Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of life
P2860
Q24514949-33A821AB-067F-44AB-8F46-B3619F23525BQ24514954-418B3824-B4C7-43FB-873A-BEECBCB0FD18Q24548638-E9EDEDDA-F29A-4678-8621-0D4F765C1053Q27318412-DF098A73-C944-4CB6-8025-098634E990FBQ28542668-51E5950A-D723-4DC4-96DD-C835C7198E5AQ33768911-78D96A6B-79FD-490D-9B15-68440BBCD2A4Q33829920-12F6C7AD-E5F3-4C29-80B3-DC58CFAC84E7Q33883854-B9DFF40F-1E18-40D1-800E-A9001EA9F351Q34004529-3894CE05-00CB-4144-A443-0D7D3E203797Q34005519-CDF81369-6D92-4E8A-B526-779C0F8ABCE2Q34007894-C41D2E81-B9E2-4306-A5CF-9DA6EA0C35EDQ34126483-0E04BA73-CA42-450C-AB94-6F25F38BC25CQ34129094-F7E06750-94FD-414C-ABF0-436F51800BCEQ34228558-B6C42425-63C1-42A6-91B2-D975EE54FC2CQ35023778-F79E0A91-045C-425E-80A1-8EE84C1AF086Q35105822-ACDB6A37-9671-4FF2-A2A0-07789D14706CQ35182263-4DB683C3-2649-44E4-AC5D-AA7A1A669A50Q35635302-E4B4A581-17CA-4717-BB8F-C5AB597FA91FQ36099003-1F788847-52C1-4A84-9CF4-6F1D88661605Q36374782-6318862C-EF57-426E-8C66-DBFA6D92C4DAQ36407775-53165B18-0BAC-45C9-BAAB-0D6C0C19D54FQ36450329-BD98B8ED-689F-4892-9B48-0FA3A75CA056Q36575494-AF986E56-463C-4095-A4F3-7D1A6996F71BQ36647936-0306123D-1121-4E7B-AFD2-43D552DDA2F1Q36694820-1D49DCB6-CFDE-4D1F-B58A-B1E6A7BDBD9BQ37522910-A9BC8D2F-DAB5-4D16-96B6-EF7B7C3FFE85Q38081358-7CC7B7FD-19C8-4431-93E6-787563BDCD3EQ38581976-278FDE71-1918-4F44-B985-6FDBE3E0D1D8Q38730774-4E7B38D3-1696-4991-AE2B-86598B7F68A0Q39521650-A859AC46-7C5D-41C6-B05A-858FE64CD6BBQ40247465-95B6EE26-73EE-4931-85B6-FF3EB50ABDA0Q40523370-AA527737-BDB1-4752-B982-317C67DC3D6EQ48189111-6325F870-7D42-425A-8DC9-A058BE4B54D0Q55409400-174A52A1-2243-439F-AAED-995D33E3E26DQ58615628-1934B306-87AB-4ED4-ADF7-40472C442F52
P2860
A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
A plasmid encoding murine gran ...... rred by a malaria DNA vaccine.
@en
A plasmid encoding murine gran ...... rred by a malaria DNA vaccine.
@nl
type
label
A plasmid encoding murine gran ...... rred by a malaria DNA vaccine.
@en
A plasmid encoding murine gran ...... rred by a malaria DNA vaccine.
@nl
prefLabel
A plasmid encoding murine gran ...... rred by a malaria DNA vaccine.
@en
A plasmid encoding murine gran ...... rred by a malaria DNA vaccine.
@nl
P2093
P1476
A plasmid encoding murine gran ...... erred by a malaria DNA vaccine
@en
P2093
Barnhart K
Hedstrom RC
Hoffman SL
Klinman DM
P304
P407
P577
1998-09-01T00:00:00Z